Yu Han
Northwestern University(US)Chinese Academy of Sciences(CN)University of Houston System(US)Changchun Institute of Applied Chemistry(CN)Photonic BioSystems (United States)(US)Pediatric Brain Tumor Foundation(US)Neurological Surgery(US)Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Publications by Year
Research Areas
Immune cells in cancer, Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, RNA Interference and Gene Delivery
Most-Cited Works
- → CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells(2016)606 cited
- → Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors(2014)576 cited
- → HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma(2019)294 cited
- → STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma(2023)204 cited
- → Myeloid-Derived Suppressive Cells Promote B cell–Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma(2019)165 cited
- → Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma